Jessica Hope Roark

Array ( [id] => 5973596 [patent_doc_number] => 20110152505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'METHOD FOR DECREASING IMMUNOGENICITY' [patent_app_type] => utility [patent_app_number] => 12/973968 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8409 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152505.pdf [firstpage_image] =>[orig_patent_app_number] => 12973968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8566048 [patent_doc_number] => 20120328619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'Trispecific Therapeutics Against Acute Myeloid Leukaemia' [patent_app_type] => utility [patent_app_number] => 13/514580 [patent_app_country] => US [patent_app_date] => 2010-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17702 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9648813 [patent_doc_number] => 08802826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-12 [patent_title] => 'Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume' [patent_app_type] => utility [patent_app_number] => 13/502427 [patent_app_country] => US [patent_app_date] => 2010-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 30092 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8637556 [patent_doc_number] => 20130029359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'MONOCLONAL ANTIBODIES AND DIAGNOSTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/510901 [patent_app_country] => US [patent_app_date] => 2010-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15147 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9936881 [patent_doc_number] => 08986687 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Compounds inhibiting CD95 signaling for the treatment of pancreatic cancer' [patent_app_type] => utility [patent_app_number] => 13/509592 [patent_app_country] => US [patent_app_date] => 2010-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9313 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8482850 [patent_doc_number] => 20120282257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'SINGLE-CHAIN VARIABLE FRAGMENT (SCFV) ABLE TO RECOGNIZE AND BIND CD99 HUMAN PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/509276 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8744 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10898310 [patent_doc_number] => 08921525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Highly-functional mutant of humanized anti-EGFR antibody variable region' [patent_app_type] => utility [patent_app_number] => 13/510516 [patent_app_country] => US [patent_app_date] => 2010-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11039 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026090 [patent_doc_number] => 08535668 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Chimeric anti-ricin antibody' [patent_app_type] => utility [patent_app_number] => 13/508108 [patent_app_country] => US [patent_app_date] => 2010-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 15092 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8566046 [patent_doc_number] => 20120328618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'DOSAGE REGIMEN FOR ADMINISTERING A CD19XCD3 BISPECIFIC ANTIBODY' [patent_app_type] => utility [patent_app_number] => 13/504665 [patent_app_country] => US [patent_app_date] => 2010-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16396 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8358641 [patent_doc_number] => 20120213801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'Phosphorylated Twist1 and cancer' [patent_app_type] => utility [patent_app_number] => 13/504981 [patent_app_country] => US [patent_app_date] => 2010-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21414 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6030951 [patent_doc_number] => 20110081339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'METHODS OF USING IL-17 RECEPTOR A ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/899290 [patent_app_country] => US [patent_app_date] => 2010-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 43878 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081339.pdf [firstpage_image] =>[orig_patent_app_number] => 12899290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110303 [patent_doc_number] => 20110189183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Antibodies against candida, collections thereof and methods of use' [patent_app_type] => utility [patent_app_number] => 12/807955 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 92766 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189183.pdf [firstpage_image] =>[orig_patent_app_number] => 12807955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101661 [patent_doc_number] => 20110165153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'ANTI CD37 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/884563 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20486 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165153.pdf [firstpage_image] =>[orig_patent_app_number] => 12884563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8503330 [patent_doc_number] => 20120302737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'COILED COIL AND/OR TETHER CONTAINING PROTEIN COMPLEXES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/496696 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 46620 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8346747 [patent_doc_number] => 20120207672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'SELECTIVE DETECTION OF BONE METASTASES IN RENAL CLEAR CELL CARCINOMA' [patent_app_type] => utility [patent_app_number] => 13/395927 [patent_app_country] => US [patent_app_date] => 2010-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 3485 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8484008 [patent_doc_number] => 20120283415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'Multivalent Antibodies' [patent_app_type] => utility [patent_app_number] => 13/395235 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11802 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10529013 [patent_doc_number] => 09255142 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-09 [patent_title] => 'Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof' [patent_app_type] => utility [patent_app_number] => 13/821844 [patent_app_country] => US [patent_app_date] => 2010-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 15180 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8197026 [patent_doc_number] => 20120121581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'Anti-Botulism Antibody Coformulations' [patent_app_type] => utility [patent_app_number] => 12/875065 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 34410 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121581.pdf [firstpage_image] =>[orig_patent_app_number] => 12875065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007048 [patent_doc_number] => 20110059079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'Antibody Coformulations' [patent_app_type] => utility [patent_app_number] => 12/875083 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 33646 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059079.pdf [firstpage_image] =>[orig_patent_app_number] => 12875083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10026120 [patent_doc_number] => 09068008 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-30 [patent_title] => 'Antibodies to carcinoembryonic antigen (CEA), methods of making same, and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/872908 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 29802 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12872908 [rel_patent_id] =>[rel_patent_doc_number] =>)